Correlation Between Transcode Therapeutics and Spruce Biosciences

Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Spruce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Spruce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Transcode Therapeutics and Spruce Biosciences, you can compare the effects of market volatilities on Transcode Therapeutics and Spruce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Spruce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Spruce Biosciences.

Diversification Opportunities for Transcode Therapeutics and Spruce Biosciences

0.0

Correlation Coefficient

Transcode Therapeutics  Spruce Biosciences

Pay attention - limited upside

The 3 months correlation between Transcode and Spruce is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Spruce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spruce Biosciences and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Spruce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spruce Biosciences has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Spruce Biosciences go up and down completely randomly.

Pair Corralation between Transcode Therapeutics and Spruce Biosciences

If you would invest  995.00  in Transcode Therapeutics on May 7, 2025 and sell it today you would earn a total of  155.00  from holding Transcode Therapeutics or generate 15.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	1.61%
Values	Daily Returns

Transcode Therapeutics  vs.  Spruce Biosciences

Transcode Therapeutics

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Transcode Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Transcode Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Spruce Biosciences

Risk-Adjusted Performance

Weakest

Over the last 90 days Spruce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Spruce Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Transcode Therapeutics and Spruce Biosciences

The main advantage of trading using opposite Transcode Therapeutics and Spruce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Spruce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spruce Biosciences will offset losses from the drop in Spruce Biosciences' long position.

The idea behind Transcode Therapeutics and Spruce Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.